This is the 7th quarterly HIV Program report after implementation of the 2011 Integrated Clinical HIV Guidelines in July 2011. A summary of the key achievements between January and March 2013 is provided below:

• Scale‐up of integrated HIV services had reached the following number of sites:

  • 825 static (607 within and 218 outside of health facilities) and 534 outreach HTC sites

  • 655 (static) ART sites

  • 580 PMTCT sites (Option B+)

  • 602 Pre‐ART sites

  • 590 sites with HIV‐exposed child follow‐up

• 460,559 persons were tested and counselled for HIV and 41,321 (9%) were HIV positive; 170,334 (37%) people tested for the first time.

• 127,167 (78%) of 163,522 women at ANC had their HIV status ascertained; 10,282 (8%) of these were HIV positive. 102,506 (89%) of 114,376 women at maternity had their HIV status ascertained; 8,306 (8%) of these were HIV positive.

• 26,881 patients started ART during this quarter; this is an 11% increase from the previous quarter (24,168), probably related to the improved management of HIV test kit supplies.

• 422,866 patients were alive and on ART by end of March 2013; 84,499 (22%) of 390,576 on first line adult regimens were on ART regimen 5A (tenofovir / lamivudine / efavirenz).

• 81%_ of adults and 78%__ of children were retained alive on ART at 12 months after ART initiation.

• A total of 11,120 HIV positive pregnant women were on ART: 4,134 (37%) of these were already on ART when getting pregnant and 6,986 (63%) started ART during pregnancy/delivery. 6,773 (97%) of pregnant women started ART due to Option B+ (in WHO clinical stage 1 or 2) and 213 (3%) due to a low CD4 count and/or WHO clinical stage 3 or 4.

• An additional 2,279 breastfeeding women started ART due to Option B+ (in WHO clinical stage 1 or 2).

• 6,695 (77%) of 8,648 women started under Option B+ were retained at 6 months after ART initiation (6‐month retention outcomes were not available for some women, mainly at sites with electronic data systems).

• 7,740 (8%) of infants discharged alive from maternity were known to be HIV exposed, 6,975 (90%) of these received ARV prophylaxis. 5,096 (73%) were enrolled in exposed child followup before age 2 months.

• A total of 10,319 HIV exposed children and 9,510 pre‐ART patients were enrolled for followup in HIV Care Clinics (HCC) during this quarter.

• 195 medical staff were newly trained and certified in PMTCT/ART and an additional 23 medical records clerks were trained in M&E for the PMTCT/ART program this quarter. This brings the total number trained in the 2011 guidelines to 5,711.

• 513 HTC counsellors and 1,239 HSAs at 152 facilities received mentoring for collection of dried blood samples for Early Infant Diagnosis and documentation of results.

• In preparation for a nationwide retraining of all HTC providers, 20 Master trainers were trained in the HTC Skills Intensive Training curriculum, who in turn trained 197 trainers.

• 418 health workers and 182 support staff at 70 facilities in the SE Zone received clinical mentoring in provision of PMTCT/ART. 45 of these health workers were in the intensive phase, 223 in the continuation phase and 150 graduated from the mentoring program this quarter.